Which statement best describes thromboelastography as a clinical test?

Which statement best describes thromboelastography as a clinical test?

• A. It assesses platelet count alone
• B. It assesses global clot formation including initiation, strength, and breakdown
• C. It measures only fibrinogen levels
• D. It measures specific clotting factor activities only

Answer: (B)

Thromboelastography provides a real-time, global view of how a clot forms and breaks down in whole blood. It tracks the entire coagulation process—from when clotting begins (initiation) to how quickly the clot grows (propagation), how strong the final clot becomes (strength), and how the clot dissolves (breakdown). Because a single test captures the interactions among platelets, fibrinogen, coagulation factors, and the fibrinolytic system, it gives a comprehensive picture of hemostasis rather than measuring just one component. This is why it best fits the description of assessing global clot formation including initiation, strength, and breakdown.

Thromboelastography provides a real-time, global view of how a clot forms and breaks down in whole blood. It tracks the entire coagulation process—from when clotting begins (initiation) to how quickly the clot grows (propagation), how strong the final clot becomes (strength), and how the clot dissolves (breakdown). Because a single test captures the interactions among platelets, fibrinogen, coagulation factors, and the fibrinolytic system, it gives a comprehensive picture of hemostasis rather than measuring just one component. This is why it best fits the description of assessing global clot formation including initiation, strength, and breakdown.